Related Experiment Video
Updated: Aug 23, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil
S J Roth1, C B Porter, L A Latson
1The Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Insights
Intravenous verapamil effectively reduced left ventricular outflow tract gradients in two pediatric patients with hypertrophic obstructive cardiomyopathy when beta blockers were contraindicated. This suggests verapamil as a potential treatment for selected cases.
Area of Science:
- Cardiology
- Pediatric Medicine
- Pharmacology
Background:
- Hypertrophic obstructive cardiomyopathy (HOCM) presents a significant challenge in pediatric patients.
- Traditional therapies like beta-adrenergic antagonists may be contraindicated or ineffective.
- Managing left ventricular outflow tract (LVOT) gradient is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the efficacy of intravenous verapamil in reducing LVOT gradient in pediatric HOCM.
- To explore verapamil as an alternative treatment when standard therapies are not suitable.
Main Methods:
- Case study of two pediatric patients with HOCM.
- Intravenous administration of verapamil.
- Measurement of LVOT gradient before and during verapamil infusion.
Main Results:
- In a 15-year-old patient, the LVOT gradient decreased from 160 to 45 torr.
- In a 3-year-old boy, the LVOT gradient reduced from 60 to 10 torr.
- Significant reduction in LVOT gradient observed in both pediatric cases.
Conclusions:
- Intravenous verapamil demonstrated effectiveness in reducing LVOT gradients in pediatric HOCM patients.
- Verapamil may serve as a viable therapeutic option for selected pediatric HOCM cases, especially when other treatments are contraindicated.
Abstract:
We report the reduction in left ventricular outflow tract gradient following the intravenous administration of verapamil to two pediatric patients with hypertrophic obstructive cardiomyopathy. Traditional therapy with beta adrenergic antagonists was relatively contraindicated in both patients. In a 15-year-old patient, the left ventricular outflow tract gradient decreased from 160 torr, at rest, to 45 torr during the verapamil infusion. In a 3-year-old boy, there was a reduction in the left ventricular outflow tract gradient from 60 torr, under basal conditions, to 10 torr during the intravenous verapamil infusion. We believe that verapamil may be effective in reducing the left ventricular outflow tract gradient in some pediatric patients with hypertrophic obstructive cardiomyopathy and may be useful in treating selected patients with this disorder.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis III: Medical Management
Cardiomyopathy VI: Nursing Management

